FRANKLIN LAKES, N.J., Dec. 16, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received pandemic orders ...
LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...
BD said it will spend approximately $60 million on the 69,000-square-foot expansion and upgrade of the plant, which it wants to transform into “one of the largest and most sophisticated plastic ...
First Shipments of Injection Devices Already Arrived in U.K. Mike Fairbourn, vice president and general manager of BD – U.K. and Ireland said, "With a 60-year history in vaccine delivery, BD is ...
BD Simplist Prefilled Ondansetron Injection Approved The FDA has approved BD Rx's Ondansetron Injection, the third drug from the new BD Simplist line of ready-to-administer prefilled generic ...
BD Rx announced that the FDA has approved Morphine Sulfate Injection, the fourth drug to be offered in the BD Simplist line of ready-to-administer prefilled injectables. Morphine Sulfate is an opioid ...
Medtech giant Beckton Dickinson (BD) has signed a deal with France's Biocorp to use the latter's near-field communication (NFC) tags in injectable devices. The agreement will see Biocorp's Injay ...
BD (Becton, Dickinson and Company), a leading global medical technology company, has now launched BD Ultra-Fine III Nano—the world's smallest pen needle in India. The BD Nano pen needle is proven to ...
When BD unveiled a four-year, $1.2 billion upgrade to its drug delivery device manufacturing last year, the company teased plans for a new factory in Europe—and now it’s showing its hand. BD has ...
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the commercial release of the BD Neopak XtraFlow Glass Prefillable Syringe and the latest capacity expansion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback